Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

The rheumatoid arthritis therapeutics market is ... globally and increased awareness about effective treatment options. Advances in biologic therapies have transformed management strategies ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Further research is needed to determine the risks and benefits of particular sequences of biologic therapies in patients with rheumatoid arthritis who require treatment change owing to inefficacy ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

Without treatment, this disease can lead to serious disability. Early and aggressive treatment of rheumatoid arthritis can help prevent joint damage from inflammation. Disease-modifying anti-rheumatic ...

A study from Spain found a subcutaneous tocilizumab biosimilar to be cost-effective when treating patients with rheumatoid ...

The classic signs of rheumatoid arthritis include pain, swelling, and stiffness of several joints. Persistent inflammation can lead to issues with mobility, fatigue, illness, and joint deformity over ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...